
Strong medical pot sales help Canopy Growth beat Q1 expectations
Canopy Growth Corp. reported fiscal first-quarter results that beat analyst expectations, despite suffering a decline in recreational cannabis sales in Canada due to COVID-19 and increased competition. Canopy, the world’s largest cannabis company by market valuation, said that its medical cannabis business outperformed in its three-month period ending June 30, while also seeing revenue gains…